Profund Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Profund Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,964	Closed	-$505K	–	1157
2023 Q1	$505K	Buy	+20,964	New	+$263K	0.03%	502

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Profund Advisors's PRVB Position: Q2 2023 in Review

Profund Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 20,964 shares — an estimated $505K sold.

Profund Advisors first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $505K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Profund Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Profund Advisors sold 20,964 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $505K.
Profund Advisors first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Profund Advisors's Provention Bio, Inc. Common Stock position peaked at $505K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Profund Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.